H.R. 1082 · 119th Congress

Shandra Eisenga Human Cell and Tissue Product Safety Act

Stage
Passed a chamber
Sponsor
John Moolenaar
Introduced
2025-02-06
Latest action
2025-06-24 · Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Action history

  1. 2025-06-24Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. 2025-06-23Motion to reconsider laid on the table Agreed to without objection.
  3. 2025-06-23On motion to suspend the rules and pass the bill Agreed to by voice vote.
  4. 2025-06-23DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.
  5. 2025-06-23Considered under suspension of the rules.
  6. 2025-06-23Mr. Bilirakis moved to suspend the rules and pass the bill.
  7. 2025-06-12Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
  8. 2025-06-12Placed on the Union Calendar, Calendar No. 127.
  9. 2025-04-29Committee Consideration and Mark-up Session Held
  10. 2025-04-29Ordered to be Reported by Voice Vote.
  11. 2025-02-06Introduced in House
  12. 2025-02-06Referred to the House Committee on Energy and Commerce.